These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 17008558)
1. Short-form Ron receptor is required for normal IFN-gamma production in concanavalin A-induced acute liver injury. Wetzel CC; Leonis MA; Dent A; Olson MA; Longmeier AM; Ney PA; Boivin GP; Kader SA; Caldwell CC; Degen SJ; Waltz SE Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G253-61. PubMed ID: 17008558 [TBL] [Abstract][Full Text] [Related]
2. The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. Wilson CB; Ray M; Lutz M; Sharda D; Xu J; Hankey PA J Immunol; 2008 Aug; 181(4):2303-10. PubMed ID: 18684919 [TBL] [Abstract][Full Text] [Related]
3. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Leonis MA; Toney-Earley K; Degen SJ; Waltz SE Hepatology; 2002 Nov; 36(5):1053-60. PubMed ID: 12395314 [TBL] [Abstract][Full Text] [Related]
4. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. Chen YQ; Fisher JH; Wang MH J Immunol; 1998 Nov; 161(9):4950-9. PubMed ID: 9794431 [TBL] [Abstract][Full Text] [Related]
5. Expression of the Short Form of RON/STK in Feline Mammary Carcinoma. Maniscalco L; Guil-Luna S; Iussich S; Gattino F; Trupia C; Millan Y; de Las Mulas JM; Cespedez RS; Saeki K; Accornero P; De Maria R Vet Pathol; 2019 Mar; 56(2):220-229. PubMed ID: 30558510 [TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production. Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421 [TBL] [Abstract][Full Text] [Related]
7. Impaired NK cell cytotoxicity by high level of interferon-gamma in concanavalin A-induced hepatitis. Dong Z; Zhang C; Wei H; Sun R; Tian Z Can J Physiol Pharmacol; 2005 Nov; 83(11):1045-53. PubMed ID: 16391713 [TBL] [Abstract][Full Text] [Related]
8. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression. Bardella C; Costa B; Maggiora P; Patane' S; Olivero M; Ranzani GN; De Bortoli M; Comoglio PM; Di Renzo MF Cancer Res; 2004 Aug; 64(15):5154-61. PubMed ID: 15289319 [TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury. Wang Y; Mei Y; Feng D; Xu L Clin Exp Immunol; 2006 Sep; 145(3):485-92. PubMed ID: 16907918 [TBL] [Abstract][Full Text] [Related]
10. The role of the receptor tyrosine kinase Ron in nickel-induced acute lung injury. McDowell SA; Mallakin A; Bachurski CJ; Toney-Earley K; Prows DR; Bruno T; Kaestner KH; Witte DP; Melin-Aldana H; Degen SJ; Leikauf GD; Waltz SE Am J Respir Cell Mol Biol; 2002 Jan; 26(1):99-104. PubMed ID: 11751209 [TBL] [Abstract][Full Text] [Related]
11. A novel accessory role of neutrophils in concanavalin A-induced hepatitis. Hatada S; Ohta T; Shiratsuchi Y; Hatano M; Kobayashi Y Cell Immunol; 2005 Jan; 233(1):23-9. PubMed ID: 15893298 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells. Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567 [TBL] [Abstract][Full Text] [Related]
13. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651 [TBL] [Abstract][Full Text] [Related]
15. Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Caldwell CC; Martignoni A; Leonis MA; Ondiveeran HK; Fox-Robichaud AE; Waltz SE Crit Care Med; 2008 May; 36(5):1585-93. PubMed ID: 18434891 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury. Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526 [TBL] [Abstract][Full Text] [Related]
17. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Peace BE; Hughes MJ; Degen SJ; Waltz SE Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422 [TBL] [Abstract][Full Text] [Related]
18. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury. Wang J; Sun R; Wei H; Dong Z; Tian Z Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711 [TBL] [Abstract][Full Text] [Related]
19. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. Liu QP; Fruit K; Ward J; Correll PH J Immunol; 1999 Dec; 163(12):6606-13. PubMed ID: 10586055 [TBL] [Abstract][Full Text] [Related]
20. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. Iwama A; Yamaguchi N; Suda T EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]